1 – 10 of 11
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Thrombospondin-4 deletion does not exacerbate muscular dystrophy in β-sarcoglycan-deficient and laminin α2 chain-deficient mice
(
- Contribution to journal › Article
- 2015
-
Mark
Deletion of integrin α7 subunit does not aggravate the phenotype of laminin α2 chain-deficient mice.
(
- Contribution to journal › Article
- 2014
-
Mark
Laminin α2 Chain-Deficiency is Associated with microRNA Deregulation in Skeletal Muscle and Plasma.
(
- Contribution to journal › Article
-
Mark
Quantitative proteomic analysis reveals metabolic alterations, calcium dysregulation and increased expression of extracellular matrix proteins in laminin α2 chain-deficient muscle.
(
- Contribution to journal › Article
-
Mark
Loss of Dystrophin and β-Sarcoglycan, Respectively, Significantly Exacerbates the Phenotype of Laminin α2 Chain-Deficient Animals.
(
- Contribution to journal › Article
- 2011
-
Mark
Transgenic Expression of Laminin α1 Chain Does Not Prevent Muscle Disease in the mdx Mouse Model for Duchenne Muscular Dystrophy.
(
- Contribution to journal › Article
-
Mark
Skeletal muscle laminin and MDC1A: pathogenesis and treatment strategies.
(
- Contribution to journal › Article
- 2010
-
Mark
Transgenic overexpression of laminin 1 chain in laminin 2 chain-deficient mice rescues the disease throughout the lifespan
(
- Contribution to journal › Article
-
Mark
Distinct roles for laminin globular domains in laminin alpha1 chain mediated rescue of murine laminin alpha2 chain deficiency.
(
- Contribution to journal › Article
- 2007
-
Mark
Dystroglycan: a possible mediator for reducing congenital muscular dystrophy?
(
- Contribution to journal › Scientific review